Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

LifeStance Health (LFST) Long-Term Debt Issuances (2020 - 2024)

Historic Long-Term Debt Issuances for LifeStance Health (LFST) over the last 5 years, with Q4 2024 value amounting to $287.8 million.

  • LifeStance Health's Long-Term Debt Issuances rose 77872.56% to $287.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $320.6 million, marking a year-over-year increase of 45505.69%. This contributed to the annual value of $287.8 million for FY2024, which is 39834.47% up from last year.
  • LifeStance Health's Long-Term Debt Issuances amounted to $287.8 million in Q4 2024, which was up 77872.56% from $32.8 million recorded in Q4 2023.
  • LifeStance Health's 5-year Long-Term Debt Issuances high stood at $287.8 million for Q4 2024, and its period low was $9.5 million during Q3 2022.
  • Over the past 5 years, LifeStance Health's median Long-Term Debt Issuances value was $29.5 million (recorded in 2021), while the average stood at $110.1 million.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first plummeted by 8798.08% in 2023, then surged by 77872.56% in 2024.
  • Quarter analysis of 5 years shows LifeStance Health's Long-Term Debt Issuances stood at $235.9 million in 2020, then plummeted by 88.89% to $26.2 million in 2021, then decreased by 24.24% to $19.8 million in 2022, then skyrocketed by 65.0% to $32.8 million in 2023, then surged by 778.73% to $287.8 million in 2024.
  • Its last three reported values are $287.8 million in Q4 2024, $32.8 million for Q4 2023, and $25.0 million during Q2 2023.